|4Jul 12, 4:13 PM ET

Eizen Joshua M 4

4 · AN2 Therapeutics, Inc. · Filed Jul 12, 2024

Insider Transaction Report

Form 4
Period: 2024-07-10
Eizen Joshua M
See Remarks
Transactions
  • Award

    Common Stock

    2024-07-10+60,00094,833 total
Footnotes (3)
  • [F1]Represents a grant of restricted stock units ("RSUs"). RSUs vest as follows: 25% vest on January 1, 2025, 50% vest on January 1, 2026 and 25% vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
  • [F2]Includes a balance of 30,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
  • [F3]Reflects the adjusted total which includes the purchase of 2,386 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2024.

Documents

2 files